Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000593927 | SCV000707085 | likely pathogenic | not provided | 2017-03-17 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV004530706 | SCV004710225 | pathogenic | TYR-related disorder | 2023-12-30 | no assertion criteria provided | clinical testing | The TYR c.1424_1433del10 variant is predicted to result in a frameshift and premature protein termination (p.Trp475Serfs*7). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in TYR are expected to be pathogenic and therefore we interpret c.1424_1433del (p.Trp475Serfs*7) as pathogenic. |